Indication
Systemic Inflammatory Response
1 clinical trial
1 product
1 drug
Clinical trial
Evaluation of Intraoperative Dexmedetomidine Use on Reducing Inflammatory Response Caused by Cardiopulmonary Bypass in Patients Undergoing Surgical Aortic Valve ReplacementStatus: Recruiting, Estimated PCD: 2023-12-31
Drug
VarlilumabProduct
Dexmedetomidine